Qingwei Cong

发表

Safety and Immunogenicity of SARS-CoV-2 Vaccines in Patients With Chronic Liver Diseases (CHESS-NMCID 2101): A Multicenter Study

H. Xiang, Yan Yan, Wenhong Zhang, 2021, Clinical Gastroenterology and Hepatology.

Metabonomics Research Progress on Liver Diseases

Mengqian Yu, Ying Zhu, Qingwei Cong, 2017, Canadian journal of gastroenterology & hepatology.

The effect of LOXL2 in hepatocellular carcinoma

Yuan Zhang, Y. Xiang, Ying Zhu, 2016, Molecular medicine reports.

Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study

H. Xiang, Xianghui Qi, Jing-wen Ai, 2022, Hepatology International.

The Silencing of LOXL2 Gene Decreases Proliferation and Metastasis in Hepatocellular Carcinoma

Y. Xiang, Y. Zhang, Ying Zhu, 2016 .

Nonlinear Relationship Between Macrocytic Anemia and Decompensated Hepatitis B Virus Associated Cirrhosis: A Population-Based Cross-Sectional Study

Ying Zhu, Qingwei Cong, T. Zhao, 2021, Frontiers in Pharmacology.

Mechanisms of Action of Mesenchymal Stem Cells in Metabolic-Associated Fatty Liver Disease

Qiumin Xu, Ying Zhu, Qingwei Cong, 2023, Stem cells international.

Non‑coding RNAs: Role of miRNAs and lncRNAs in the regulation of autophagy in hepatocellular carcinoma (Review)

Qiumin Xu, Ying Zhu, Qingwei Cong, 2023, Oncology reports.

Research progress in the metabolic reprogramming of hepatocellular carcinoma (Review)

Qingwei Cong, S. Yi, Wenyue Gao, 2024, Molecular medicine reports.

Biological functions and potential mechanisms of miR‑143‑3p in cancers (Review)

Qingwei Cong, Dandan Liu, Ying Zhu, 2024, Oncology reports.

Research Progress on the Role of Epigenetic Methylation Modification in Hepatocellular Carcinoma

Qingwei Cong, Wenyue Gao, Jing Wang, 2024, Journal of hepatocellular carcinoma.